Arbor Vita Corporation Announces a Collaboration and License Agreement With Becton, Dickinson and Company (BDX) for the Development of a Diagnostic Test for Cervical Cancer
11/10/2008 12:26:52 PM
SUNNYVALE, CA--(Marketwire - November 10, 2008) - Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, today announced a strategic collaboration in women's health with BD (Becton, Dickinson and Company), a leading global medical technology company. The collaboration and license agreement is initially focused on the development of a commercial diagnostic for cervical cancer, which globally affects more than 500,000 women each year.
comments powered by